Prestige Consumer Healthcare (PBH) Operating Income (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Operating Income of $82.5 million in Q4 2025, up 3.54% quarter-over-quarter from $79.7 million in Q3 2025, and down 10.3% on a YoY basis from $92.0 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Operating Income (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Operating Income history runs 16 years deep, the most recent figure standing at $82.5 million for Q4 2025.
- In Q4 2025, Operating Income fell 10.3% year-over-year to $82.5 million; the TTM figure through Dec 2025 stood at $322.3 million (down 2.47% YoY), while the FY2025 annual figure was $336.8 million, down 1.65% from the prior year.
- Operating Income was $82.5 million for Q4 2025 at Prestige Consumer Healthcare, up from $79.7 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $92.0 million in Q4 2024 to a low of -$281.0 million in Q1 2023.
- Historically, Operating Income has averaged $64.6 million across 5 years, with a median of $83.5 million in 2021.
- The sharpest annual moves came in 2023 and 2024: Operating Income sank 462.93% in 2023, then soared 129.24% in 2024.
- A 5-year view of Operating Income shows it stood at $82.6 million in 2021, then increased by 5.56% to $87.2 million in 2022, then declined by 0.4% to $86.8 million in 2023, then increased by 5.91% to $92.0 million in 2024, then declined by 10.3% to $82.5 million in 2025.
- The last three Operating Income figures came in at $82.5 million (Q4 2025), $79.7 million (Q3 2025), and $71.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14.03 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 193.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -48.28 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -78.32 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 81.33 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 82.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 82.49 Mn |
| Sep 30, 2025 | 79.67 Mn |
| Jun 30, 2025 | 71.76 Mn |
| Mar 31, 2025 | 88.43 Mn |
| Dec 31, 2024 | 91.96 Mn |
| Sep 30, 2024 | 84.34 Mn |
| Jun 30, 2024 | 72.05 Mn |
| Mar 31, 2024 | 82.15 Mn |
| Dec 31, 2023 | 86.83 Mn |
| Sep 30, 2023 | 88.25 Mn |
| Jun 30, 2023 | 85.19 Mn |
| Mar 31, 2023 | -281.00 Mn |
| Dec 31, 2022 | 87.18 Mn |
| Sep 30, 2022 | 84.38 Mn |
| Jun 30, 2022 | 87.01 Mn |
| Mar 31, 2022 | 77.43 Mn |
| Dec 31, 2021 | 82.59 Mn |
| Sep 30, 2021 | 78.56 Mn |
| Jun 30, 2021 | 91.34 Mn |
| Mar 31, 2021 | 70.94 Mn |